|
In the year 2000, Femarelle® began its commercialization stage and consumers around the world have started to enjoy the benefits that it provides.
Femarelle®'s uniqueness lies in its being a Selective Estrogen Receptor Modulator- a SERM. The selectivity in the estrogen receptor bondage provides both menopausal symptoms relief and bone health, without affecting the sensitive tissues in the breast and uterus.
Thus, Femarelle® provides a safe and effective solution for the management of menopause.
The scientific activity surrounding Femarelle® provides published studies in leading scientific journals worldwide, as well as international recognition and acceptance by the medical community both in practice and in leading medical conventions. The research process continues and new studies are constantly being conducted in order to provide comprehensive data proving both the efficacy and safety of use of the product.
Our Partner in India is:
Svizera Healthcare
29/33 Ancillary Ind. Estate
Deonar, Govandi
Mumbai 400 043
For more information regarding where you can find Femarelle® in India, please contact:
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
We thank you for visiting our website and both Se-cure Pharmaceuticals and Svizera Healthcare are at your service and will be happy to hear from you.
|
|
